相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
Elodie Bohers et al.
PHARMACEUTICALS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cell-Free DNA: Hope and Potential Application in Cancer
Yan-yan Yan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer
Zachary T. Weber et al.
GENOME MEDICINE (2021)
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour et al.
CANCER CELL (2020)
The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA
Tenna V. Henriksen et al.
MOLECULAR ONCOLOGY (2020)
Impact of tumor heterogeneity and tissue sampling for genetic mutation testing: a systematic review and post hoc analysis
Stephanie L. Swift et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Cell-free DNA concentration in patients with clinical or mammographic suspicion of breast cancer
Michal Peled et al.
SCIENTIFIC REPORTS (2020)
Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patient
Lisa Welter et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2020)
Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
Stefan Grabuschnig et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Progress in adjuvant systemic therapy for breast cancer
Noam F. Ponde et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis
Maria Palmieri et al.
CANCER CELL INTERNATIONAL (2019)
Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study
Marissa C. van Maaren et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer Patients
Leila Jahangiri et al.
CANCERS (2019)
Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer
Fiona Tsui-Fen Cheng et al.
CASE REPORTS IN ONCOLOGICAL MEDICINE (2019)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
David Tamborero et al.
GENOME MEDICINE (2018)
Tumor Heterogeneity in Breast Cancer
Gulisa Turashvili et al.
FRONTIERS IN MEDICINE (2017)
Patterns and predictors of first and subsequent recurrence in women with early breast cancer
Y. M. Geurts et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
Yu-Hsiang Chen et al.
NPJ BREAST CANCER (2017)
Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3
Fabrice Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
Amita Patnaik et al.
CANCER DISCOVERY (2016)
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
Eric Talevich et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
Clinical management of breast cancer heterogeneity
Dimitrios Zardavas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors
Amit G. Deshwar et al.
GENOME BIOLOGY (2015)
SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
Christopher A. Miller et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
ST14 Gene Variant and Decreased Matriptase Protein Expression Predict Poor Breast Cancer Survival
Jaana M. Kauppinen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis
MJ Pellikainen et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
分享论文
